Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

It's ALL in the diagnosis.

Louis M Staudt1

  • 1Metabolism Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA. Istaudt@mail.nih.gov

Cancer Cell
|June 28, 2002
PubMed
Summary

Molecular diagnosis is advancing cancer treatment. Gene expression profiling of pediatric acute lymphoblastic leukemia (ALL) indicates personalized therapies are nearing reality.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Cancer cell·2026
Same author

Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.

Blood cancer discovery·2026
Same author

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Blood advances·2026
Same author

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.

Blood advances·2026
Same author

RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Axes of biological variation in diffuse large B cell lymphoma.

Cancer cell·2026

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Personalized medicine aims to tailor treatments to individual patient tumor profiles.
  • Gene expression profiling is a key technology for understanding cancer at a molecular level.

Discussion:

  • Recent studies in pediatric acute lymphoblastic leukemia (ALL) show significant progress toward molecular diagnosis.
  • This progress suggests a shift from generalized to individualized cancer treatment strategies.

Key Insights:

  • Molecular diagnosis enables identification of specific genetic abnormalities in cancer cells.
  • This identification is crucial for developing targeted therapies.

Outlook:

  • The findings indicate that molecularly tailored treatments for pediatric ALL are imminent.
  • This approach promises to revolutionize pediatric cancer care.